J&J Renova Comparative Efficacy Study Among Post-Approval Requirements
This article was originally published in The Rose Sheet
Executive Summary
A comparative efficacy study between newly approved Renova .02% and the currently marketed .05% tretinoin cream formula is among the data commitments requested of marketer Johnson & Johnson's Ortho Dermatological. The new Renova formula will be available by prescription only in November.
You may also be interested in...
Biore Fine Line Gel Patches Comparable To Top Rx Wrinkle Brand, Firm Says
Biore Fine Line Gel Patches are comparable to the leading prescription antiwrinkle cream, producing noticeable results in just four weeks, the Andrew Jergens subsidiary claims. The patches can be "compared to applying a soothing eye cream over 20 times during the night," Biore said.
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle